健康权益

最新新闻

• 评级变动
  Goldman Sachs Maintains HealthEquity(HQY.US) With Sell Rating, Cuts Target Price to $88
  \u5e02\u573a\u8d44\u8baf · 2026/5/29
• Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $115
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  Citizens JMP Maintains HealthEquity(HQY.US) With Buy Rating, Cuts Target Price to $111
  \u5e02\u573a\u8d44\u8baf · 2026/6/1
• 评级变动
  A Quick Look at Today's Ratings for HealthEquity(HQY.US), With a Forecast Between $108 to $125
  \u5e02\u573a\u8d44\u8baf · 2026/5/29
• 评级变动
  BofA Securities Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $125
  \u5e02\u573a\u8d44\u8baf · 2026/8/20
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN) and Healthequity (HQY)
  TipRanks · 2026/5/29
• 评级变动
  BofA Securities Maintains HealthEquity(HQY.US) With Buy Rating, Announces Target Price $115
  \u5e02\u573a\u8d44\u8baf · 2026/4/22
• 评级变动
  J.P. Morgan Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $123
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Barrington Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/8/24
• 评级变动
  Deutsche Bank Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $128
  \u5e02\u573a\u8d44\u8baf · 2026/3/19
• 评级变动
  KeyBanc Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $125
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• A Quick Look at Today's Ratings for HealthEquity(HQY.US), With a Forecast Between $105 to $125
  \u5e02\u573a\u8d44\u8baf · 2026/8/29
• Wells Fargo Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $125
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  BTIG Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $115
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• Barclays Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $110
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• Deutsche Bank Maintains HealthEquity(HQY.US) With Buy Rating, Raises Target Price to $142
  \u5e02\u573a\u8d44\u8baf · 2026/8/31
• 评级变动
  RBC Capital Initiates HealthEquity(HQY.US) With Buy Rating, Announces Target Price $108
  \u5e02\u573a\u8d44\u8baf · 2026/5/29
• 评级变动
  RBC Capital Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $108
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  BMO Capital Upgrades HealthEquity(HQY.US) to Buy Rating, Raises Target Price to $105
  \u5e02\u573a\u8d44\u8baf · 2026/4/9
• 评级变动
  BofA Securities Maintains HealthEquity(HQY.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/5/13

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。